Jun 20Delix Announces Completion of 1st Cohort Dosing, Dose Escalation Approval in PhI Trial for DLX-001
Nov 30, 2022ARTIS Portfolio founders named to Forbes 30 Under 30 for Healthcare & Consumer Technology